Armando, a 71-year-old with an active lifestyle, was midway through a round of golf when a strange sensation crept into his abdomen after drinking water. It was just a fleeting moment; one he brushed ...

As part of its “Speaking Out” video series, CURE spoke with Dr. Tracy L. Rose, on behalf of the Bladder Cancer Advocacy Network, about how currently available agents are being investigated in ...

Investigators hypothesize that patients presented later to their health care providers during the first year of the pandemic. Investigators in Ireland report that the rate of more advanced and more ...

Please provide your email address to receive an email when new articles are posted on . “Most studies enroll patients who are of a younger age than the actual representative population,” Kessler told ...

CHAPEL HILL, North Carolina--A new study has demonstrated that patients with advanced bladder cancers whose tumors have a mutated FGFR3 gene respond to immunotherapy treatment in a manner that is ...

Certain healthcare conditions often go unspoken, leading to silent struggles that affect the lives of many. Overactive bladder (OAB) and fecal incontinence (FI) are two such conditions, impacting ...

The medication is being tested as adjuvant therapy in patients with locally advanced urothelial cancer. Locally advanced urothelial cancer (UC), variably defined as muscle-invasive UC with a large or ...

Although cisplatin is not recommended for patients with renal impairment, studies have been performed using cisplatin at lower or split doses. These studies indicate that administration of low-dose ...

Researchers report a study has demonstrated that patients with advanced bladder cancers whose tumors have a mutated FGFR3 gene respond to immunotherapy in a manner that is similar to patients without ...